SCHEMBL8550198

SCHEMBL8550198

O=C(OC1CCN(Cc2ccc(Cl)cc2)CC1)c1ccc(F)cc1

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.57
DRD2 P14416 1/20 0.55
DRD4 P21917 1/20 0.55
HTR2A P28223 1/20 0.54
GAA P10253 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8551048 0.99 ADRB2 (0.56) ADRB2DRD2DRD4HTR2AGAA
SCHEMBL8551065 0.95 DRD4 (0.60) DRD2DRD4GAA
Hydrochloric Acid SCHEMBL8550602 0.93 DRD2 (0.58) DRD2DRD4GAA
SCHEMBL8551160 0.89 SCN1A (0.61) ADRB2HTR2AGAA
SCHEMBL8555980 0.89 ADRB2 (0.56) ADRB2HTR2AGAA
SCHEMBL8549980 0.89 GPR183 (0.60) DRD2DRD4
SCHEMBL8553670 0.89 SCN1A (0.61) ADRB2DRD2DRD4GAA
SCHEMBL8550706 0.88 DRD2 (0.62) DRD2DRD4
SCHEMBL8552599 0.88 SIGMAR1 (0.64) DRD2DRD4
SCHEMBL8552224 0.88 CARM1 (0.58) ADRB2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1084329-C Benzyl piepridine derivs as pharmaceutical agents HOFFMANN LA ROCHE (CH) 2002-05-08 CN disclosed
EP-0871613-A1 BENZYL PIPERIDINE DERIVATIVES AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 1998-10-21 EP disclosed
CN-1183768-A Benzyl piepridine derivs as pharmaceutical agents HOFFMANN LA ROCHE (CH) 1998-06-03 CN disclosed
US-5753679-A SCIZOPHRENIA HOFFMANN-LA ROCHE INC. (US) 1998-05-19 US disclosed
WO-1996035666-A1 BENZYL PIPERIDINE DERIVATIVES AS PHARMACEUTICAL AGENTS F.HOFFMANN-LA ROCHE AG (CH) 1996-11-14 WO disclosed